People in brief | Stada, Derma E, Denmark

People in brief | Stada, Derma E, Denmark
Peter Goldschmidt joins Stada from Sandoz

3 September 2018 - Deborah Wilkes

Stada, Derma E and the Danish Medicines Agency have all recently announced people changes.

Goldschmidt takes the reins at Stada

Peter Goldschmidt has now succeeded Claudio Albrecht as chief executive officer of Stada Arzneimittel. The change was announced in early 2018 (click here to read the News story).

Goldschmidt joins the German generics and OTC company from Sandoz – the generics division of Novartis – where he was president of Sandoz US and Head North America.

Stada said Goldschmidt would use the next 100 days to get to know the group, its partners and its customers intensively, and would then share his strategic priorities with the team.

The company noted that Albrecht would not be taking a seat on Stada's Supervisory Board under the German government's "cooling-off" regulation of 2009.

Derma E recruits from L'Oréal

Skincare specialist Derma E has appointed Brenda Wu as president and chief executive officer with immediate effect. She also becomes a member of the US-based company's board of directors.

Wu joins Derma E from L'Oréal, where she spent a decade working with well-known brands such as Skinceuticals, Giorgio Armani Beauty, Lancôme and Kiehl's. Most recently, Wu was US general manager of Skinceuticals.

Derma E was recently acquired by Topix Pharmaceuticals, which is a portfolio company of private-equity firm New Mountain Capital (click here to read the News story).

Brun chairs Task Force on Big Data

The Danish Medicines Agency has announced that Nikolai Brun, its director of medical evaluation and biostatistics, has been elected chair of the Task Force on Big Data in the pharmaceutical area.

The task force, which was established in May 2017, is a collaboration between the European Medicines Agency (EMA) and Europe's Heads of Medicines Agencies (HMA). It aims to identify advantages and challenges of using big data for the development of medicines.

Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions

Click tags below for more information on topics:


Back to Industry News

Share this page: